Short communication · 31 Mar 2025
PerspectivePublished 21 Jan 2021
Pharmacokinetics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pharmacokinetic difficulties have been identified as a leading source of novel chemical entity attrition in medication development. The revelation of such difficulties during clinical drug development is connected with high development costs and time investments. Drug clearance, or the elimination of medications from the body, is a fundamental topic in pharmacokinetics, similar to creatinine clearance. The clearance of a medication is rarely assessed directly in clinical practise.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in Journal of In Silico & In Vitro Pharmacology.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of In Silico & In Vitro Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Nitisha Goyal”
